Geneva tests treatment for long-covid

Friday, 18 November 2022 06:30

The Geneva University Hospital is taking part in a trial to test a promising treatment for long-covid.

A Geneva biopharmaceutical company, GeNeuro, has developed an antibody which targets the persistence of inflammation after an infection.

The trial will last for 6 months and is due to start early next year. Recruitment for test subjects has already begun. Researchers are hoping for around 200 volunteers.

The results should be known in the second half of next year.

The company says long-covid is associated more with the Delta variant of covid – it seems to be less common with Omicron.

More from Bitesize News

Husband and wife found dead in Germany and Switzerland

A joint police operation between German and Aargau police has been launched as a husband and wife have both been found dead.
Swisscom fined for competition law violation.

Swisscom has been fined CHF 18m for breaking the cartel law and unfair competition.
Speeders found after social media videos

Two drivers posted themselves driving at high-speed on social media and have been tracked down by police.
One idea unites all political parties

One idea has united all parties in the Geneva Grand Council – from the Greens to the Swiss People’s Party.
Elderly woman swipes unclaimed cash

An elderly woman who took a CHF 1,000 that had not been collected by an ATM user has been ordered to pay it back - plus CHF 400.
Govt to delay funding decision for UNRWA

The Swiss government is putting off a decision on whether to re-start funding to the UN Palestinian relief organisation UNRWA.